A new method for identifying bacterial infections quickly and accurately
MS Diagnostic Bacterial Identification Library
['FUNDING_R01'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-10795029
This study is working on a new way to quickly and accurately identify bacterial and fungal infections using special markers found in germs, which could help doctors treat patients more effectively.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10795029 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel diagnostic platform that utilizes microbial membrane glycolipids to create unique chemical fingerprints for identifying bacterial and fungal infections. By analyzing these glycolipids through mass spectrometry, the researchers aim to provide rapid and accurate diagnoses, which are crucial for effective patient treatment and antibiotic management. The project seeks to address the limitations of current diagnostic methods by offering a more efficient and reliable approach to pathogen identification, potentially transforming how infections are diagnosed in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suspected of having bacterial or fungal infections who require timely and accurate diagnostic testing.
Not a fit: Patients with non-infectious conditions or those who do not require diagnostic testing for bacterial or fungal infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of bacterial and fungal infections, improving patient outcomes and antibiotic stewardship.
How similar studies have performed: Previous research has shown promise in using chemical signatures for pathogen identification, but this specific approach utilizing glycolipids is relatively novel and untested.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ERNST, ROBERT K — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: ERNST, ROBERT K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: bacteria infection, bacterial disease, Bacterial Infections